Rapidly progressive glomerulonephritis (RPGN; crescentic glomerulonephritis)
Bedside summary
A clinical-pathological syndrome, not a single disease: nephritic presentation with loss of renal function over days-weeks and crescents in >50% of glomeruli on biopsy. Three immunopathological groups: (1) pauci-immune/ANCA-associated (commonest — GPA/MPA/EGPA), (2) anti-GBM disease, (3) immune-complex (lupus, IgA/IgA vasculitis, post-infectious, MPGN, cryoglobulinaemia). A medical emergency where rapid biopsy + serology and empirical immunosuppression preserve kidney function — treat first, the window is short.
Red flags
- Creatinine doubling over days to a week with active sediment — treat now, biopsy urgently
- Pulmonary haemorrhage/haemoptysis with hypoxia — pulmonary-renal syndrome, ITU
- Oligo-anuria / dialysis requirement at presentation — narrowing window for renal recovery
- Multisystem features (rash, sinus/ENT, neuropathy, haemoptysis) — systemic vasculitis
- Delay to biopsy/serology — the main modifiable cause of lost kidneys
Assessment
Differential diagnosis
- ANCA-associated vasculitis (MPO/PR3) — pauci-immune RPGN
- Anti-GBM disease (linear IgG, pulmonary-renal syndrome)
- Immune-complex: lupus nephritis, IgA/IgA vasculitis, post-infectious GN, MPGN, cryoglobulinaemia (often with endocarditis/hepatitis C)
- Thrombotic microangiopathy (HUS/TTP/malignant hypertension/scleroderma renal crisis) mimicking rapid GFR loss
- Acute tubular necrosis / acute interstitial nephritis (bland or non-nephritic sediment)
Investigations
- URGENT serology ('renal emergency screen'): ANCA (MPO/PR3), anti-GBM, ANA/dsDNA, complement C3/C4, cryoglobulins, hepatitis B/C, ASOT
- Urine microscopy (dysmorphic RBCs + red cell/cellular casts — the nephritic hallmark), PCR/ACR
- U&E/creatinine/eGFR with trend (rapid rise), FBC, CRP/ESR, blood cultures (endocarditis)
- CXR/CT chest for pulmonary haemorrhage; ENT/sinus and nerve assessment if vasculitis
- URGENT renal biopsy — crescents; immunofluorescence pattern (pauci-immune vs linear IgG vs granular immune-complex) classifies the cause and directs therapy
- Pre-immunosuppression screen: HBV/HCV/HIV, TB, pregnancy test, baseline FBC/LFTs
Management
- Recognise the syndrome early (rising creatinine + active nephritic sediment) and escalate immediately — send the renal emergency serology screen and arrange urgent biopsy
- Start empirical high-dose corticosteroids (pulse IV methylprednisolone) when RPGN is strongly suspected and the patient is deteriorating, before definitive results, in discussion with nephrology
- Direct definitive therapy by cause once biopsy/serology known:
- - ANCA-associated: induction with glucocorticoids + rituximab (or cyclophosphamide); add plasma exchange for severe renal failure/dialysis-dependence or pulmonary haemorrhage (per PEXIVAS-informed selective use)
- - Anti-GBM: urgent plasma exchange + steroids + cyclophosphamide (treat before dialysis dependence)
- - Immune-complex (lupus/IgA/post-infectious/cryo): treat the underlying disease (e.g. lupus induction, treat infection/HCV, crescentic IgA steroids +/- cyclophosphamide)
- Supportive care: manage AKI complications (hyperkalaemia, acidosis, overload), RRT for standard indications, treat/ventilate pulmonary haemorrhage
- Infection prophylaxis (PCP) and monitoring for immunosuppression toxicity; plan maintenance immunosuppression (especially ANCA/lupus) to prevent relapse
Drugs & doses
Disposition
Complications & pitfalls
- Irreversible ESKD if treatment delayed
- Life-threatening pulmonary haemorrhage
- Immunosuppression toxicity: infection, cyclophosphamide/rituximab adverse effects
- Disease relapse (particularly ANCA vasculitis)
- Complications of severe AKI (hyperkalaemia, acidosis, overload)
Exam pearls
- RPGN is defined by the CLINICAL tempo (fast GFR loss + nephritic sediment) and confirmed by CRESCENTS on biopsy — think of it as a syndrome with three serological buckets: pauci-immune (ANCA), linear (anti-GBM) and granular (immune-complex).
- Send the 'renal emergency screen' (ANCA, anti-GBM, ANA/dsDNA, complement, cryoglobulins, hepatitis serology) and get an urgent biopsy the same day — empirical pulse steroids can start before results in a deteriorating patient.
- Plasma exchange is standard for anti-GBM and is used selectively (severe renal failure/dialysis dependence or pulmonary haemorrhage) in ANCA disease following PEXIVAS.
- The commonest single cause is ANCA-associated vasculitis; always look for the other organs (lungs, ENT, skin, nerves).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.